$VTEX

do Carmo Thomaz Junior Geraldo sold $20K of VTEX

do Carmo Thomaz Junior Geraldo (Chief Executive Officer) sold 4,808 shares of VTEX (VTEX) at $4.06 on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · do Carmo Thomaz Junior Geraldo
Published Jul 8, 2026, 1:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VTEX
Neutral
medium confidence
Mentioned
$VTEX
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTEXNeutralLow
01

Why it matters

Traders may monitor insider activity for sentiment, but the pre-arranged nature of the sale generally lowers informational content about near-term business prospects.

02

Market read

A routine 10b5-1 insider sale was newly filed, offering limited incremental information beyond confirming transaction details.

03

What to watch

The article provides no context on total insider holdings changes over time, whether sales are part of a larger scheduled program, or any concurrent company news.

Relevance 2/10Novelty 4/10Timing: new Form 4 filed 2026-07-08, covering a sale executed 2026-07-06

Background

The article is a SEC Form 4 insider transaction disclosure for VTEX, reporting an officer sale executed under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$VTEXNeutralMedium confidence
Context

CEO do Carmo Thomaz Junior Geraldo sold 4,808 shares of VTEX at $4.0600 on 2026-07-06 under a 10b5-1 plan, per Form 4.

Expected impact

Likely limited immediate price impact; any reaction should be muted given the stated 10b5-1 plan.

Evidence & confidence

The filing discloses the transaction size, price, and that it was executed under a pre-arranged 10b5-1 plan, which reduces the likelihood of it reflecting new negative information.

Market effects

No direct sector read-through; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as reduced confidence, especially if paired with other negative signals not present here.

Key entities

  • VTEX

    Company whose CEO insider sale is disclosed on SEC Form 4.

  • do Carmo Thomaz Junior Geraldo

    VTEX CEO who sold 4,808 shares at $4.0600 per share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a